Wuxi Bio (02269) spent 49.23 million Hong Kong dollars to buy back 1.6 million shares on June 22nd.
WuXi Biologics (02269) announced on June 22, 2026 that the company will spend 49.2393 million Hong Kong dollars to buy back 1.6 million shares, at a repurchase price of 30.66-31.14 Hong Kong dollars per share.
WUXI BIO (02269) announcement, on June 22, 2026, the company spent 49.2393 million Hong Kong dollars to repurchase 1.6 million shares, with a repurchase price of 30.66-31.14 Hong Kong dollars per share.
Related Articles
Weak demand combined with operational pressures: Lucid (LCID.US) announced a 18% reduction in its US workforce and the elimination of the COO position.
US Stock Market Move | SpaceX (SPCX.US) falls more than 9%, accumulating a 20% drop over three consecutive trading days.
Shenzhen Senior Technology Material (06067): Public offering in Hong Kong receives oversubscription of 1563.16 times.
Weak demand combined with operational pressures: Lucid (LCID.US) announced a 18% reduction in its US workforce and the elimination of the COO position.
US Stock Market Move | SpaceX (SPCX.US) falls more than 9%, accumulating a 20% drop over three consecutive trading days.
Shenzhen Senior Technology Material (06067): Public offering in Hong Kong receives oversubscription of 1563.16 times.
RECOMMEND
